Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The interplay between probiotic metabolites, host health, and inhibition of pathogens has increasingly attracted interest but remains unresolved due to the complex molecular interactions among these factors. We investigated the action of cell-free supernatants (CFSs) from two probiotic bacteria, spp. () HN019 and () HN001 and their effect against the bacterial pathogen 2457T (). The CFSs from HN019 exhibited a higher antibacterial effect against growth than the CFSs from HN001, independent of the carbon source utilized. This effect correlated with higher formate within the CFSs from HN019. As expected, the antimicrobial effects of CFSs were stronger against free cells than for infecting host cells. A synergistic effect of the CFSs with additional small organic molecules such as indole-3-lactate and formate was found. Such interplay between CFSs, indole-3-lactate, and formate was reflected by altered metabolic rates by in the presence of HN019 CFSs both in the solution and under biofilm-forming conditions. The synergistic effect between different components acting on gives reasons to believe that suitably designed mixtures of probiotic metabolic products and small-molecule effectors bear promise for successfully combating pathogens.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsinfecdis.4c00796DOI Listing

Publication Analysis

Top Keywords

spp hn019
8
hn019 hn001
8
cfss
8
cfss hn019
8
indole-3-lactate formate
8
hn019
5
synergistic formate
4
formate cell-free
4
cell-free supernatant
4
supernatant fermented
4

Similar Publications

The interplay between probiotic metabolites, host health, and inhibition of pathogens has increasingly attracted interest but remains unresolved due to the complex molecular interactions among these factors. We investigated the action of cell-free supernatants (CFSs) from two probiotic bacteria, spp. () HN019 and () HN001 and their effect against the bacterial pathogen 2457T ().

View Article and Find Full Text PDF

Objective: To evaluate the adjunctive use of the probiotic Bifidobacterium animalis subsp. lactis HN019 (B. lactis HN019) to conventional therapy on clinical and microbiological parameters in patients with generalized gingivitis.

View Article and Find Full Text PDF

Xylooligosaccharide (XOS) is an attractive prebiotic mainly due to its bifidogenic effect. However, commercial XOS with different compositions is often applied in the food industry at different doses without specifications. In this study, we evaluated the bifidogenic activity of XOS at different doses with either mixtures or pure fractions with different degrees of polymerization (DP), using three strains of spp.

View Article and Find Full Text PDF

In vitro fermentation of prebiotic oligosaccharides by Bifidobacterium lactis HN019 and Lactobacillus spp.

Anaerobe

February 2014

Callaghan Innovation Research Limited, PO Box 31-310, Lower Hutt 5040, New Zealand.

The utilisation of various prebiotic oligosaccharides by probiotic strains of Bifidobacterium lactis, Lactobacillus rhamnosus and Lactobacillus acidophilus was investigated in order to determine the synbiotic potential of various prebiotic/probiotic combinations. Analysis by HPLC and high-performance anion-exchange chromatography of the cell-free medium taken during growth of the three probiotic bacteria showed differences in the consumption of the various oligosaccharides. Analysis of galactooligosaccharides showed that both L.

View Article and Find Full Text PDF